168 related articles for article (PubMed ID: 27339453)
21. A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.
Biesinger S; Michaels HA; Quadros AS; Qian Y; Rabovsky AB; Badger RS; Jalili T
Eur J Clin Nutr; 2016 Jan; 70(1):10-6. PubMed ID: 26059745
[TBL] [Abstract][Full Text] [Related]
22. Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.
Zhao X; Chen Y; Yang G; Li X; Tang X; Yang Q; Peng L; Li J; Liang Z; Li A; Wang W; Huang M; Liu T; Li X; Jiang W
Am Heart J; 2023 Oct; 264():10-19. PubMed ID: 37276913
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
[TBL] [Abstract][Full Text] [Related]
25. Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.
Wicklow B; Wittmeier K; T' Jong GW; McGavock J; Robert M; Duhamel T; Dolinsky VW
Biochem Cell Biol; 2015 Oct; 93(5):522-30. PubMed ID: 26305052
[TBL] [Abstract][Full Text] [Related]
26. Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): statistical analysis plan for a randomized, blinded, crossover trial.
Zhao X; Li X; Liu T; Yang G; Chen Y; Huang M; Zhao L; Li X; Jiang W
Trials; 2024 Jan; 25(1):45. PubMed ID: 38218924
[TBL] [Abstract][Full Text] [Related]
27. A series of N-of-1 trials to assess the therapeutic interchangeability of two enalapril formulations in the treatment of hypertension in Addis Ababa, Ethiopia: study protocol for a randomized controlled trial.
Alemayehu C; Mitchell G; Aseffa A; Clavarino A; McGree J; Nikles J
Trials; 2017 Oct; 18(1):470. PubMed ID: 29017595
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
29. The HYPERFlax trial for determining the anti-HYPERtensive effects of dietary flaxseed in newly diagnosed stage 1 hypertensive patients: study protocol for a randomized, double-blinded, controlled clinical trial.
Caligiuri SP; Penner B; Pierce GN
Trials; 2014 Jun; 15():232. PubMed ID: 24938224
[TBL] [Abstract][Full Text] [Related]
30. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Hedner T; Himmelmann A
J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
[TBL] [Abstract][Full Text] [Related]
31. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
Samimagham HR; Azad MH; Hooshyar D; Haddad M; Arabi M; KazemiJahromi M
Trials; 2021 Jul; 22(1):435. PubMed ID: 34229729
[TBL] [Abstract][Full Text] [Related]
33. Research protocol: effect of natural S-equol on blood pressure and vascular function--a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension.
Liu ZM; Ho SC; Chen YM; Xie YJ; Huang ZG; Ling WH
BMC Complement Altern Med; 2016 Mar; 16():89. PubMed ID: 26928904
[TBL] [Abstract][Full Text] [Related]
34. IPP-rich milk protein hydrolysate lowers blood pressure in subjects with stage 1 hypertension, a randomized controlled trial.
Boelsma E; Kloek J
Nutr J; 2010 Nov; 9():52. PubMed ID: 21059213
[TBL] [Abstract][Full Text] [Related]
35. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
Feig DI; Soletsky B; Johnson RJ
JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266
[TBL] [Abstract][Full Text] [Related]
36. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
Chrysant SG; Littlejohn T; Izzo JL; Kereiakes DJ; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Am J Cardiovasc Drugs; 2012 Aug; 12(4):233-43. PubMed ID: 22799613
[TBL] [Abstract][Full Text] [Related]
37. Effects of sang-qi granules on blood pressure and endothelial dysfunction in stage I or II hypertension: study protocol for a randomized double-blind double-simulation controlled trial.
Shi H; Yang D; Qiao J; Sun R; Li R; Zhu C; Jing R; Liu L; Huang L; Li L
Trials; 2020 Jan; 21(1):12. PubMed ID: 31907056
[TBL] [Abstract][Full Text] [Related]
38. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
39. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.
Turner RS; Thomas RG; Craft S; van Dyck CH; Mintzer J; Reynolds BA; Brewer JB; Rissman RA; Raman R; Aisen PS;
Neurology; 2015 Oct; 85(16):1383-91. PubMed ID: 26362286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
